Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-30
2011-08-30
Loewe, Sun Jae (Department: 1622)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S338000, C514S403000, C546S200000, C546S275400, C548S362500
Reexamination Certificate
active
08008327
ABSTRACT:
Disclosed indazoles compounds that are useful as antagonists of CCR1 activity and are thus useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of CCR1 including autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. Also disclosed are pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.
REFERENCES:
patent: 4999363 (1991-03-01), Oshima et al.
patent: 5118701 (1992-06-01), Oshima et al.
patent: 5242931 (1993-09-01), Oshima et al.
patent: 5302596 (1994-04-01), Oshima et al.
patent: 5534481 (1996-07-01), Suzuki et al.
patent: 5612360 (1997-03-01), Boyd et al.
patent: 5616537 (1997-04-01), Yokota et al.
patent: 5670452 (1997-09-01), Suzuki et al.
patent: 5760028 (1998-06-01), Jadhav et al.
patent: 5763616 (1998-06-01), Suzuki et al.
patent: 5770544 (1998-06-01), Yokota et al.
patent: 5973156 (1999-10-01), Chambers et al.
patent: 6025374 (2000-02-01), Castro Pineiro et al.
patent: 6107321 (2000-08-01), Madin
patent: 6211219 (2001-04-01), MacLeod et al.
patent: 6326382 (2001-12-01), Villalobos et al.
patent: 6331640 (2001-12-01), Fotouhi et al.
patent: 6498255 (2002-12-01), Villalobos et al.
patent: 6716978 (2004-04-01), Marfat
patent: 6784182 (2004-08-01), Liebeschuetz et al.
patent: 6803384 (2004-10-01), Fotouhi et al.
patent: 6855715 (2005-02-01), Liebeschuetz et al.
patent: 6878725 (2005-04-01), Liebeschuetz et al.
patent: 6900196 (2005-05-01), Liebeschuetz et al.
patent: 6936611 (2005-08-01), Liebeschuetz et al.
patent: 7049297 (2006-05-01), Zhang et al.
patent: 7053078 (2006-05-01), Liebeschuetz et al.
patent: 7129264 (2006-10-01), Smallheer et al.
patent: 7223782 (2007-05-01), Atkinson et al.
patent: 7429609 (2008-09-01), Ohi et al.
patent: 2002/0037860 (2002-03-01), D'Andrea et al.
patent: 2002/0052373 (2002-05-01), Zorn et al.
patent: 2004/0127536 (2004-07-01), Bhagwat et al.
patent: 2005/0009876 (2005-01-01), Bhagwat et al.
patent: 2005/0020564 (2005-01-01), Atkinson et al.
patent: 2005/0108582 (2005-05-01), Fung
patent: 2005/0208582 (2005-09-01), Ohi et al.
patent: 2005/0261339 (2005-11-01), Ohi et al.
patent: 2006/0252781 (2006-11-01), Basarab et al.
patent: 2006/0281739 (2006-12-01), Gadek et al.
patent: 2007/0004761 (2007-01-01), Basarab et al.
patent: 2008/0262040 (2008-10-01), Callahan et al.
patent: 2009/0054397 (2009-02-01), Ohi et al.
patent: 2010/0093724 (2010-04-01), Cook et al.
patent: 2011/0034512 (2011-02-01), Disalvo et al.
patent: 2011/0086846 (2011-04-01), Cook et al.
patent: 345747 (1989-12-01), None
patent: 1201268 (2002-05-01), None
patent: 10001478 (1998-01-01), None
patent: 9217475 (1992-10-01), None
patent: 9401415 (1994-01-01), None
patent: 9500509 (1995-05-01), None
patent: 9617842 (1996-06-01), None
patent: 9711945 (1997-04-01), None
patent: 9719073 (1997-05-01), None
patent: 9723480 (1997-07-01), None
patent: 9803504 (1998-01-01), None
patent: 9923076 (1999-05-01), None
patent: 0021920 (2000-04-01), None
patent: 0076970 (2000-12-01), None
patent: 0076971 (2000-12-01), None
patent: 0100656 (2001-01-01), None
patent: 0210137 (2002-02-01), None
patent: 03087085 (2003-10-01), None
patent: 03101968 (2003-12-01), None
patent: 03105853 (2003-12-01), None
patent: 2004043924 (2004-05-01), None
patent: 2004056831 (2004-07-01), None
patent: 2004094372 (2004-11-01), None
patent: 2005016929 (2005-02-01), None
patent: 2006091496 (2006-08-01), None
patent: 2006125119 (2006-11-01), None
patent: 2007002293 (2007-01-01), None
patent: 2007028083 (2007-03-01), None
patent: 2007102883 (2007-09-01), None
patent: 2008011131 (2008-01-01), None
patent: 2009024585 (2009-02-01), None
patent: 2009037570 (2009-03-01), None
patent: 2009134666 (2009-11-01), None
patent: 2009137338 (2009-11-01), None
patent: 2010036632 (2010-04-01), None
Bruneau et al, caplus an 1990:478384.
Kitamura, capus an 2008:94643.
Doherty, caplus an 2009:583109.
International Search Report for PCT/US2009/041485 mailed Jun. 29, 2009.
Alzheimer's Disease. Retrieved online Dec. 15, 2010. http:/www.cnn.com/HEALTH/mentalhealt/alzheimers.
Carter, P.H. et al., “N-aryl pyrazoles,indazoles and azaindazoles as antagonists of CC chemokine receptor 1: patent cooperation treaty applications WO2010036632, WO2009134666 and WO2009137337”. Expert Opinion Ther. Patents, 2010, 20(11), p. 1-10.
Cheng, J-F, et al., “CCR1 Antagonists”. Molecular Diversity, Kluwer Academic Publishers, vol. 12, No. 1, Jun. 17, 2008, p. 17-23.
DiSalvo Darren
Kuzmich Daniel
Mao Can
Razavi Hossein
Sarko Christopher Ronald
Boehringer Ingelheim International GmbH
Bottino Anthony P.
Loewe Sun Jae
Morris Michael P.
LandOfFree
Indazole compounds as CCR1 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indazole compounds as CCR1 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indazole compounds as CCR1 receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2768225